Lexicon Pharmaceuticals
LXRX
#7142
Rank
ยฃ0.38 B
Marketcap
ยฃ1.05
Share price
-1.41%
Change (1 day)
88.57%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : ยฃ64.33 Million

According to Lexicon Pharmaceuticals 's latest financial reports the company's total liabilities are ยฃ64.33 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Lexicon Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31ยฃ0.12 B13.55%
2023-12-31ยฃ0.10 B67.73%
2022-12-31ยฃ63.79 M269.34%
2021-12-31ยฃ17.27 M-50.35%
2020-12-31ยฃ34.78 M-84.83%
2019-12-31ยฃ0.22 B-6.29%
2018-12-31ยฃ0.24 B-10.22%
2017-12-31ยฃ0.27 B5.66%
2016-12-31ยฃ0.25 B4.39%
2015-12-31ยฃ0.24 B105.29%
2014-12-31ยฃ0.12 B90.87%
2013-12-31ยฃ63.04 M-3.04%
2012-12-31ยฃ65.02 M-23.98%
2011-12-31ยฃ85.53 M10.16%
2010-12-31ยฃ77.64 M33.29%
2009-12-31ยฃ58.25 M29.98%
2008-12-31ยฃ44.81 M7.62%
2007-12-31ยฃ41.64 M-22.14%
2006-12-31ยฃ53.48 M-30.61%
2005-12-31ยฃ77.07 M63.71%
2004-12-31ยฃ47.08 M-28.62%
2003-12-31ยฃ65.95 M231.83%
2002-12-31ยฃ19.87 M33.31%
2001-12-31ยฃ14.9 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Eterna Therapeutics
ERNA
ยฃ1.95 M-96.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
ยฃ6.90 B 10,640.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
ยฃ0.88 B 1,269.15%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ1.16 B 1,716.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
ยฃ38.90 B 60,372.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
ยฃ0.61 B 850.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
ยฃ2.84 B 4,325.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ0.39 B 513.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
ยฃ0.40 B 529.11%๐Ÿ‡บ๐Ÿ‡ธ USA